Vols. 1-2, no. 6 issued by the Psychopharmacology Service Center of the National Institute of Mental Health; v. 2, no. 7-v. 19, no. 4 by the Institute's National Clearinghouse for Mental Health Information
Notes
Content throughout is cropped due to physical condition of item. Table of contents listed on title page.
CameraCanon EOS 5D Mark II
CopyrightPublic domain. United States Government document.
byUnited States. Alcohol, Drug Abuse, and Mental Health Administration; National Clearinghouse for Mental Health Information (U.S.); Psychopharmacology Service Center (U.S.); Medical Literature, inc
byUnited States. Alcohol, Drug Abuse, and Mental Health Administration; National Clearinghouse for Mental Health Information (U.S.); Psychopharmacology Service Center (U.S.); Medical Literature, inc
byUnited States. Alcohol, Drug Abuse, and Mental Health Administration; National Clearinghouse for Mental Health Information (U.S.); Psychopharmacology Service Center (U.S.); Medical Literature, inc
byUnited States. Alcohol, Drug Abuse, and Mental Health Administration; National Clearinghouse for Mental Health Information (U.S.); Psychopharmacology Service Center (U.S.); Medical Literature, inc
byUnited States. Alcohol, Drug Abuse, and Mental Health Administration; National Clearinghouse for Mental Health Information (U.S.); Psychopharmacology Service Center (U.S.); Medical Literature, inc
byUnited States. Alcohol, Drug Abuse, and Mental Health Administration; National Clearinghouse for Mental Health Information (U.S.); Psychopharmacology Service Center (U.S.); Medical Literature, inc
byUnited States. Alcohol, Drug Abuse, and Mental Health Administration; National Clearinghouse for Mental Health Information (U.S.); Psychopharmacology Service Center (U.S.); Medical Literature, inc
byUnited States. Alcohol, Drug Abuse, and Mental Health Administration; National Clearinghouse for Mental Health Information (U.S.); Psychopharmacology Service Center (U.S.); Medical Literature, inc